138 related articles for article (PubMed ID: 37633413)
1. Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature.
Gatta E; Maltese V; Cavadini M; Anelli V; Bambini F; Buoso C; Facondo P; Pirola I; Delbarba A; Cappelli C
Endocr Pract; 2023 Nov; 29(11):897-901. PubMed ID: 37633413
[TBL] [Abstract][Full Text] [Related]
2. Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption.
Gatta E; Bambini F; Buoso C; Gava M; Maltese V; Anelli V; Delbarba A; Pirola I; Cappelli C
Front Endocrinol (Lausanne); 2022; 13():1080108. PubMed ID: 36561558
[TBL] [Abstract][Full Text] [Related]
3. SIMULTANEOUS INTAKE OF LIQUID L-T4 FORMULATION AND IRON SALT: FACT OR FICTION?
Maltese V; Gatta E; Facondo P; Anelli V; Cavadini M; Buoso C; Bambini F; Delbarba A; Pirola I; Cappelli C
Acta Endocrinol (Buchar); 2023; 19(1):54-58. PubMed ID: 37601720
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
6. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
7. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
[TBL] [Abstract][Full Text] [Related]
8. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
9. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
10. Resistance to levothyroxine in a bariatric surgery patient: an indication for liquid formulation?
Hommel C; Delgrange E
Acta Clin Belg; 2017 Feb; 72(1):72-75. PubMed ID: 27362875
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption.
Goldberg AS; Tirona RG; Asher LJ; Kim RB; Van Uum SH
Thyroid; 2013 Nov; 23(11):1374-8. PubMed ID: 23647409
[TBL] [Abstract][Full Text] [Related]
12. Levothyroxine Interactions with Food and Dietary Supplements-A Systematic Review.
Wiesner A; Gajewska D; Paśko P
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33801406
[TBL] [Abstract][Full Text] [Related]
13. L-T4 Therapy in Enteric Malabsorptive Disorders.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A
Front Endocrinol (Lausanne); 2021; 12():626371. PubMed ID: 33708175
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers.
Persiani S; Sala F; Manzotti C; Colovic M; Zangarini M; Donazzolo Y; Barbetta B; Vitalini C; Giacovelli G; Benvenuti C; Rovati LC
Drug Res (Stuttg); 2016 Mar; 66(3):136-40. PubMed ID: 26125285
[TBL] [Abstract][Full Text] [Related]
15. Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study.
Fallahi P; Ferrari SM; Materazzi G; Ragusa F; Ruffilli I; Patrizio A; Miccoli P; Antonelli A
Laryngoscope Investig Otolaryngol; 2018 Oct; 3(5):405-408. PubMed ID: 30410995
[TBL] [Abstract][Full Text] [Related]
16. The administration of L-thyroxine as soft gel capsule or liquid solution.
Vita R; Fallahi P; Antonelli A; Benvenga S
Expert Opin Drug Deliv; 2014 Jul; 11(7):1103-11. PubMed ID: 24896369
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: A double-blind placebo-controlled trial of levothyroxine (L-T
Walshaw PD; Gyulai L; Bauer M; Bauer MS; Calimlim B; Sugar CA; Whybrow PC
Bipolar Disord; 2018 Nov; 20(7):594-603. PubMed ID: 29869405
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of soy isoflavones combined with soy protein on serum concentration of interleukin-6 and tumour necrosis factor-α among post-menopausal women? A systematic review and meta-analysis of randomized controlled trials.
Gholami A; Mollanoroozy E; Reza Baradaran H; Hariri M
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):10-24. PubMed ID: 34455600
[TBL] [Abstract][Full Text] [Related]
20. Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: a meta-analysis.
Laurent I; Tang S; Astère M; Wang KR; Deng S; Xiao L; Li QF
Endocrine; 2018 Jul; 61(1):28-35. PubMed ID: 29572710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
